Page last updated: 2024-11-07

pilocarpine and Growth Disorders

pilocarpine has been researched along with Growth Disorders in 3 studies

Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.

Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jones, RF1
Matsui, M1
Motomura, D1
Karasawa, H1
Fujikawa, T1
Jiang, J1
Komiya, Y1
Takahashi, S1
Taketo, MM1
Hasan, W1
Cowen, T1
Barnett, PS1
Elliot, E1
Coskeran, P1
Bouloux, PM1

Trials

1 trial available for pilocarpine and Growth Disorders

ArticleYear
The sweating apparatus in growth hormone deficiency, following treatment with r-hGH and in acromegaly.
    Autonomic neuroscience : basic & clinical, 2001, Jun-20, Volume: 89, Issue:1-2

    Topics: Acetylcholinesterase; Acromegaly; Adult; Antigens, Differentiation; Biopsy; Female; Growth Disorders

2001

Other Studies

2 other studies available for pilocarpine and Growth Disorders

ArticleYear
THE SYNDROME OF MARCHESANI.
    The British journal of ophthalmology, 1961, Volume: 45, Issue:5

    Topics: Abnormalities, Multiple; Child; Child, Preschool; Ciliary Body; Consanguinity; Craniofacial Abnormal

1961
Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype.
    Proceedings of the National Academy of Sciences of the United States of America, 2000, Aug-15, Volume: 97, Issue:17

    Topics: Animals; Body Weight; Carbachol; Digestive System; Digestive System Abnormalities; Female; Fertility

2000